Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Tanahashi, N. | Fukuuchi, Y. | Tomita, M. | Matsuoka, S. | Takeda, H.
Affiliations: Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan
Abstract: We examined whether or not any difference in erythrocyte aggregability (RBC-A) exists between stroke patients with diabetes mellitus and those without diabetes mellitus. The subjects comprised 117 patients at the chronic phase of cerebral infarction (at least 2 months after onset). The patients were divided into two groups: group A, those with cerebral infarction and diabetes mellitus (N=35), aged 60±10 YO (mean±SD); and group B, those with cerebral infarction but without diabetes mellitus (N=82), aged 61±7 YO. For comparison with the erythrocyte aggregability in the stroke patients, we also undertook measurements in 52 age-matched healthy human volunteers (59±9 YO: the control group) and 44 age-matched patients with diabetes mellitus without macroangiopathy (60±7 YO; the DM group). The erythrocyte aggregability was determined using the whole blood erythrocyte aggregometer developed by us previously (Am J Physiol 251:H1205-H1210, 1986) with concomitant estimation of blood factors such as the hematocrit, albumin:globulin ratio and concentration of fibrinogen. The RBC-A values were 0.164±0.024/s in group A, 0.148±0.024/s in group B, 0.122±0.027/s in the control group and 0.142±0.023/s in the DM group, respectively. The RBC-A values in group A, group B and the DM group were significantly (p<0.01, p<0.01, p<0.01) higher than that in the control group, and the RBC-A value in group A was significantly (p<0.01) higher than that in the DM group. A significant difference (p<0.01) in RBC-A values was noted between groups A and B. Although the values of the hematocrit and albumin:globulin ratio did not differ between groups A and B, the concentration of fibrinogen in group A (350±79 mg/dl) was significantly (p<0.01) higher than that in group B (313±81 mg/dl). The above results suggest that diabetes mellitus exerted a deleterious effect on the patients with cerebral infarction from the hemorheological standpoint.
Keywords: erythrocyte aggregation, hemorheology, cerebral infarction, diabetes mellitus
DOI: 10.3233/CH-1993-13210
Journal: Clinical Hemorheology and Microcirculation, vol. 13, no. 2, pp. 253-259, 1993
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl